We thus speculate that modulating CD73/adenosine signaling in the lung tumor microenvironment is an attractive strategy to limit tumor progression, improve antitumor immune responses, and avoid escape from therapy in combination with radiotherapy and potentially radioimmunotherapy. The gene discussed is NT5E; the disease is neoplasm.